MicroTech Medical (Hangzhou) Co., Ltd. (2235.HK)
HKSE · HKD · Healthcare · Medical Devices
HK$6.71 (-0.30%) as of
Key statistics
- Market cap
- 2.64B
- P/E (TTM)
- 29.17
- Forward P/E
- 19.04
- EPS (TTM)
- 0.230
- Dividend yield
- 0.00%
- 52-week range
- 5.700 – 8.280
- Beta
- 0.51
- Revenue (TTM)
- 828.99M
- Profit margin
- 9.98%
- Analyst target
- HK$10.58
- Volume
- 17.10k
About MicroTech Medical (Hangzhou) Co., Ltd.
MicroTech Medical (Hangzhou) Co., Ltd. provides diabetes management, diabetes treatment, and diabetes monitoring and treatment medical devices in China and internationally. The company offers Equil patch insulin pump systems; AiDEX and LinX continuous glucose monitoring systems; POCT analyzer systems; closed-loop artificial pancreas systems; blood glucose monitoring systems; Exactive Pro blood glucose, blood ketone, and uric acid monitoring system; API open platform; and diabetes digital management software. It also involved in scientific research and technical services; business services; wholesale and retail; manufacturing; and commercials business. MicroTech Medical (Hangzhou) Co., Ltd. was incorporated in 2011 and is headquartered in Hangzhou, the People's Republic of China.
- Sector
- Healthcare
- Industry
- Medical Devices
- Headquarters
- Hangzhou, China
- Employees
- 702
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.